Hyun Cheol Chung

Researcher Next ID · RN-005693

Researcher · Social Sciences

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Social Sciences

Engineering

Medicine

Legal and Regulatory Analysis

Linguistic, Cultural, and Literary Studies

Military Technology and Strategies

Gastric Cancer Management and Outcomes

Colorectal Cancer Treatments and Studies

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30445-9
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.02105
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31827-5
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(11)61873-4
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)61121-x

No projects listed.